Health
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a whitepaper demonstrating how Counterpart Assistant (CA) technology suppo
About this update from Clover Pakistan Limited
[{"type":"image","alt":"Clover Health Investments, Corp.","displaySize":"","headline":null,"caption":"Clover Health Investments, Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":69,"url":"https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1HrSYo.eR7ZNai2k9C6CsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207","width":300,"height":69}},"lazy":false},{"type":"text","content":"New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.","length":142,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a whitepaper demonstrating how Counterpart Assistant (CA) technology supports value‑based care in high Area Deprivation Index (ADI) neighborhoods.","length":430,"tagName":"p"},{"type":"text","content":"Primary care in high ADI neighborhoods is frequently delivered by small, non‑urban practices operating with limited care‑coordination infrastructure and fragmented clinical data. The analysis in Counterpart’s latest whitepaper examines how CA’s advanced clinical technology supports early detection, disease progression tracking, and proactive interventions, capabilities not typically available to such practices.","length":414,"tagName":"p"},{"type":"text","content":"Key highlights from the whitepaper include:","length":43,"tagName":"p"},{"type":"text","content":"Higher Diagnosis Rates: Patients from socioeconomically disadvantaged neighborhoods (SEDN) attributed to a CA PCP who joined Clover Health from another MA plan were more likely to receive their first known diagnosis of diabetes, chronic kidney disease (CKD), chronic heart failure (CHF), or chronic obstructive pulmonary disease (COPD) in their first year after plan enrollment. Diagnosis rates were 75% higher for diabetes; 89% higher for CKD; 89% higher for CHF; and 70% higher for COPD.","length":489,"tagName":"p"},{"type":"text","content":"Diagnosis at Earlie...